NINDS Neuroscience Funding Announcements

NINDS Exploratory/Developmental Projects in Translational Research (R21)

Funding Contact(s): Christina Vert, M.S.
Funding Categories: Translational Research

Brief Description:
The goal of this Funding Opportunity Announcement (FOA) is to support any research activities required to advance candidate therapeutics through Investigational New Drug (IND), Investigational Device Exemption (IDE), or 510(K) submission to the Food and Drug Administration (FDA), and ready them for clinical testing for neurological disorders. Projects should include a strong biological rationale for the intended approach, supporting data from rigorously designed experiments, and proposed studies that exhibit methodological rigor. Such projects, if successful, should lead directly to or support another project (e.g. cooperative agreement in translational research) that will include all remaining activities for submission of an IND, IDE, or 510(k) application to the FDA. The scope includes only preclinical development activities for therapeutic drugs, devices, and biologics; development of diagnostics or rehabilitation strategies cannot be supported. Clinical research, basic research, and studies of disease mechanism are outside the program scope.

Grant Mechanism: R21
NIH Guide: PAR-13-023
Release Date: 2012-11-19
Expiration Date: 2015-01-08